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Diversity in practice
Following years of hard work we are pleased to announce that 
The Malta College of Pharmacy Practice has been included in the 
Fourth Schedule of the Health Care Profession Act as a professional 
organisation representing the Pharmacy Profession.
	Maria	Cordina	BPharm(Hons), PhD(QUB) 
Editor
Email:	president@mcppnet.org
While the College fulfilled all the criteria 
necessary for inclusion from its inception, 
accomplishing the deed, proved to be 
somewhat of an arduous task. Nevertheless, 
we are very pleased with the outcome and 
look forward to continuing our service to 
the profession.
This edition of the Journal illustrates 
the growth and diversity of the profession 
in Malta as a reflection of the international 
scene and the transitions in our country. 
Through the Journal, the Malta College 
of Pharmacy Practice aims to support the 
profession in all its facets and to encourage 
good communication between practitioners, 
scientists, regulators and other healthcare 
professionals with the ultimate aim of 
improving patient care. 
One such transition is Malta’s 
accession to the EU. This event brought 
with it significant upheaval within the 
pharmaceutical sector as documented in the 
paper entitled ‘The impact of EU legislation 
on medicines in Malta’. Due to EU legislation 
Malta has faced significant challenges 
relating to availability of medicines which 
possibly had an impact on rational drug 
use. On a more positive note, we read that 
Malta will benefit from a Twinning project 
with the Netherlands, through which the 
Registrar of the Pharmacy Council together 
with registrars’ of other regulating bodies, 
as well as council members, will benefit 
from intensive training on the relevant 
EU Directives related to the respective 
professions. The discussion during the 
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recent launch of this project brought to 
light a number of issues that require further 
clarification, highlighting the importance of 
the proposed training.
The management of diabetes using 
insulin is a highly topical issue. This 
paper provides an update based on current 
evidence thus supporting rational use of 
drugs. Additionally practical information 
with regards to the delivery and 
administration of insulin is also provided. 
It is essential for health care professionals 
to be well versed in the latter aspects and 
address them during patient interventions. 
Successful management is highly dependent 
not only on drug action but also on delivery 
and administration.
The paper comparing long-acting beta2-
adrenoreceptor agonists aims to dispel any 
misconceptions about these commonly used 
medicines in the management of asthma and 
COPD. While both formoterol and salmeterol 
fall within the same classification there 
are a number of distinct pharmacological 
differences between the two which have 
a significant impact on management and 
patient outcomes. Healthcare professionals 
dealing with NHS medicines should find 
this paper of particular interest due to the 
recent availability of formotorol instead of 
salmeterol on the local NHS.
Probiotics appear to be generating 
significant interest in the medical literature 
with a number of claims being made. The 
author identifies these and provides a clear 
picture regarding evidence, or the lack of it, 
relating to these claims.
Various countries have evolved and 
adopted different models of prescribing, 
pharmacist prescribing being one of them. 
The paper on pharmacist prescribing 
reviews the different models of pharmacist 
prescribing in the USA, UK and other 
countries. In Malta we still pertain to 
the traditional prescribing model, which, 
nevertheless, necessitates attention. The 
College fully endorses Legal Notice (L.N.) 
292 of 2006, Medicines Act, Prescription 
and Dispensing Requirements Rules, 2006 
as illustrated in a previous editorial of 
this Journal. We are further offering our 
support to DG Public Health Regulation 
by publishing the Checklist for prescribing 
and dispensing, based on the above Legal 
Notice, which has recently been circulated 
to healthcare professionals. We strongly 
urge health care professionals to abide by 
this LN in the interest of patient safety.
In our quest to enhance communication 
between the different sectors of the 
pharmaceutical profession, we have invited 
a paper from PRIMA, the Pharmaceutical 
Research and Development Industry 
Malta Association. This organisation is 
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a member of The European Federation 
of Pharmaceutical Industries and 
Associations (EFPIA) which represents the 
research-based pharmaceutical industry 
operating in Europe. We would like to 
take this opportunity to encourage 
further submissions from all sectors of the 
pharmaceutical industry.
The importance of having a strong 
and well structured primacy care system 
is addressed in the paper entitled Primary 
Care: QuoVadis? It also stresses the need 
to adopt a multidisciplinary approach to 
patient care. The authors have taken the 
opportunity to introduce The Mediterranean 
Institute of Primary Care (MIPC) which 
is a newly formed non-governmental 
organization aimed at supporting research 
and training within the domain of primary 
care in the Mediterranean region.
On a final note we would like to 
congratulate the Pharmacy Council on the 
publication of the revised Code of Ethics of 
the Pharmaceutical Profession. The updated 
Code reflects the current trends in practice; 
it especially highlights the profession’s shift 
from a product to a patient-oriented one. 
We have included The Code in the Journal 
primarily to support the Council’s work and 
to further encourage pharmacists to read 
and practice by the code.
